BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33442450)

  • 1. Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population.
    Lee GH; Phyo WW; Loo WM; Kwok R; Ahmed T; Shabbir A; So J; Koh CJ; Hartono JL; Muthiah M; Lim K; Tan PS; Lee YM; Lim SG; Dan YY
    World J Hepatol; 2020 Dec; 12(12):1228-1238. PubMed ID: 33442450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population.
    Wang X; Liu Z; Wang K; Wang Z; Sun X; Zhong L; Deng G; Song G; Sun B; Peng Z; Liu W
    Front Genet; 2016; 7():140. PubMed ID: 27532011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.
    Liao S; An K; Liu Z; He H; An Z; Su Q; Li S
    J Clin Lab Anal; 2022 Sep; 36(9):e24626. PubMed ID: 35881683
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lisboa QC; Nardelli MJ; Pereira PA; Miranda DM; Ribeiro SN; Costa RSN; Versiani CA; Vidigal PVT; Ferrari TCA; Couto CA
    World J Hepatol; 2020 Oct; 12(10):792-806. PubMed ID: 33200017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
    Kitamoto A; Kitamoto T; Nakamura T; Ogawa Y; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Nakao K; Sekine A; Chayama K; Nakajima A; Hotta K
    Endocr J; 2014; 61(7):683-9. PubMed ID: 24785259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining genetic associations with hepatic steatosis in Mexican-origin adults.
    Trejo MJ; Morrill KE; Klimentidis YC; Garcia DO
    Ann Hepatol; 2023; 28(5):101120. PubMed ID: 37271481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.
    Kanth VV; Sasikala M; Rao PN; Steffie Avanthi U; Rao KR; Nageshwar Reddy D
    World J Hepatol; 2014 Jun; 6(6):435-42. PubMed ID: 25018854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
    Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
    Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population.
    Lee Y; Cho EJ; Choe EK; Kwak MS; Yang JI; Oh SW; Yim JY; Chung GE
    Sci Rep; 2024 Apr; 14(1):9753. PubMed ID: 38679617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and long-term mortality of patients with non-MAFLD hepatic steatosis.
    Fan H; Liu Z; Zhang P; Wu S; Han X; Huang Y; Zhu Y; Chen X; Zhang T
    Hepatol Int; 2023 Jun; 17(3):615-625. PubMed ID: 37000387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease.
    Tortora R; Rispo A; Alisi A; Imperatore N; Crudele A; Ferretti F; Nobili V; Miele L; Gerbino N; Caporaso N; Morisco F
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30189691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease.
    Wu JT; Liu SS; Xie XJ; Liu Q; Xin YN; Xuan SY
    Lipids Health Dis; 2020 Feb; 19(1):29. PubMed ID: 32093693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of
    Choochuay K; Kunhapan P; Puangpetch A; Tongsima S; Srisawasdi P; Sobhonslidsuk A; Sungkanuparph S; Biswas M; Sukasem C
    World J Hepatol; 2024 Mar; 16(3):366-378. PubMed ID: 38577531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants.
    Liu Z; Suo C; Shi O; Lin C; Zhao R; Yuan H; Jin L; Zhang T; Chen X
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):e855-e875. PubMed ID: 33387670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic-associated fatty liver disease (MAFLD) in coeliac disease.
    Rispo A; Imperatore N; Guarino M; Tortora R; Alisi A; Cossiga V; Testa A; Ricciolino S; Fiorentino A; Morisco F
    Liver Int; 2021 Apr; 41(4):788-798. PubMed ID: 33319459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype.
    Mazzini FN; Cook F; Gounarides J; Marciano S; Haddad L; Tamaroff AJ; Casciato P; Narvaez A; Mascardi MF; Anders M; Orozco F; Quiróz N; Risk M; Gutt S; Gadano A; Méndez García C; Marro ML; Penas-Steinhardt A; Trinks J
    Metabolomics; 2021 Jun; 17(7):58. PubMed ID: 34137937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.
    Mosca A; Fintini D; Scorletti E; Cappa M; Paone L; Zicari AM; Nobili V; Byrne CD
    Liver Int; 2018 Dec; 38(12):2301-2308. PubMed ID: 30176114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
    Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
    Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study.
    Krawczyk M; Stachowska E; Milkiewicz P; Lammert F; Milkiewicz M
    Digestion; 2016; 93(2):139-48. PubMed ID: 26745555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.
    Zusi C; Mantovani A; Olivieri F; Morandi A; Corradi M; Miraglia Del Giudice E; Dauriz M; Valenti L; Byrne CD; Targher G; Maffeis C
    Dig Liver Dis; 2019 Nov; 51(11):1586-1592. PubMed ID: 31255630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.